Physician

Wail E Asfour, M.D.

According to 2025 Medicare claims, Wail Asfour, M.D. (NPI: 1720038680) practices cardiology in the Lake County-Porter County-Jasper County, IN market, with the plurality of this provider's patient population coming from Lake, IN. This provider's primary affiliated billing organization is CARDIOVASCULAR CONSULTANTS PC (NPI: 1538106711; TIN: 351701266) and primary practice location at 46322-2081. Asfour is affiliated with the Powers Health Partners ACO (ACO ID: A3632), participating under the MSSP model.

Asfour's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 998 traditional Medicare patients, billed 10,488 HCPCS/CPT codes, and received $898,994 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,825 prescription claims across 674 beneficiaries totaling $747,788 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 15 claims. Open Payments data shows 120 records totaling $133,716. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $381,131 to $747,788. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $23,137 and ending at $21,320.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,764	16,747	$1,071,160
2016	2,032	14,189	$1,003,746
2017	1,569	11,241	$819,230
2018	1,426	10,553	$849,627
2019	1,508	11,277	$1,138,518
2020	1,281	10,681	$887,085
2021	1,182	9,883	$926,257
2022	1,178	10,901	$1,024,038
2023	1,061	11,353	$1,039,142
2024	998	10,488	$898,994

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	779	8,595	$381,131
2016	789	8,472	$426,576
2017	811	8,595	$481,937
2018	814	8,644	$570,618
2019	754	7,399	$580,873
2020	677	6,469	$659,573
2021	648	6,113	$716,042
2022	641	5,814	$710,552
2023	676	6,166	$876,569
2024	674	5,825	$747,788

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	124	$4,650
2016	15	239	$107,816
2017	N/R	67	$1,822
2018	N/R	59	$26,165
2019	14	84	$2,457
2020	N/R	76	$2,093
2021	N/R	64	$2,602
2022	N/R	100	$3,440
2023	N/R	15	$875
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	384	402	$89
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	216	833	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	623	1,380	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	198	267	$58
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	181	185	$45

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	341	16,920	$316,615
Entresto	Sacubitril/Valsartan	150	6,514	$137,949
Xarelto	Rivaroxaban	128	6,555	$119,230
Farxiga	Dapagliflozin Propanediol	34	1,440	$27,328
Januvia	Sitagliptin Phosphate	11	990	$18,804

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$23,201	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$110,515	Boehringer Ingelheim International GmbH
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Wail E. Asfour, M.D.?

Tedicare shows public-source Medicare data for Wail E. Asfour, M.D. (NPI 1720038680), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wail E. Asfour, M.D. have ACO affiliation data?

Wail E. Asfour, M.D. is shown with ACO affiliation data for Powers Health Partners ACO (MSSP, ACO ID A3632).

What billing organization is linked to Wail E. Asfour, M.D.?

Wail E. Asfour, M.D. is linked to CARDIOVASCULAR CONSULTANTS PC (billing NPI 1538106711) in the available physician profile data.

Does Wail E. Asfour, M.D. have Open Payments data?

Wail E. Asfour, M.D. has 120 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.